BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26685888)

  • 1. Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study.
    Zhang P; Hu WL; Cheng B; Zeng YJ; Wang XH; Liu TZ; Zhang WB
    Int Urol Nephrol; 2016 Mar; 48(3):325-33. PubMed ID: 26685888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
    Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
    Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
    Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
    J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.
    Song L; Shen W; Zhang H; Wang Q; Wang Y; Zhou Z
    Bosn J Basic Med Sci; 2016 Jul; 16(3):201-8. PubMed ID: 27294569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Ligustri Lucidi Fructus with Ecliptae Herba and their phytoestrogen or phytoandrogen like active pharmaceutical ingredients alleviate oestrogen/testosterone-induced benign prostatic hyperplasia through regulating steroid 5-α-reductase.
    Tao R; Liu E; Zhao X; Han L; Yu B; Mao H; Yang W; Gao X
    Phytomedicine; 2022 Jul; 102():154169. PubMed ID: 35636178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
    Miyamoto H; Yao JL; Chaux A; Zheng Y; Hsu I; Izumi K; Chang C; Messing EM; Netto GJ; Yeh S
    BJU Int; 2012 Jun; 109(11):1716-26. PubMed ID: 22221549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of receptor expression with prostate volume in benign prostatic hyperplasia.
    Sreenivasulu K; Nandeesha H; Dorairajn LN; Rajesh NG
    Indian J Pathol Microbiol; 2019; 62(1):99-102. PubMed ID: 30706868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic effects of docosahexaenoic acid on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
    Wang C; Luo F; Zhou Y; Du X; Shi J; Zhao X; Xu Y; Zhu Y; Hong W; Zhang J
    Exp Cell Res; 2016 Jul; 345(2):125-33. PubMed ID: 25849092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular distribution of retinoic acid receptor-alpha in benign hyperplastic and malignant human prostates: comparison with androgen, estrogen and progesterone receptor status.
    Gyftopoulos K; Sotiropoulou G; Varakis I; Barbalias GA
    Eur Urol; 2000 Sep; 38(3):323-30. PubMed ID: 10940708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin.
    Thornton MJ; Taylor AH; Mulligan K; Al-Azzawi F; Lyon CC; O'Driscoll J; Messenger AG
    Exp Dermatol; 2003 Apr; 12(2):181-90. PubMed ID: 12702147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of quartz head contact laser ablation for large prostates using 980-nm laser: a comparative prospective study against that for small- and medium-sized prostates.
    Shaker HS; Saafan A; Yassin MM; Fawzy M; Shoeb MS
    Urology; 2015 Feb; 85(2):452-6. PubMed ID: 25481233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate hyperplasia caused by long-term obesity is characterized by high deposition of extracellular matrix and increased content of MMP-9 and VEGF.
    Silva SA; Gobbo MG; Pinto-Fochi ME; Rafacho A; Taboga SR; Almeida EA; Góes RM; Ribeiro DL
    Int J Exp Pathol; 2015 Feb; 96(1):21-30. PubMed ID: 25529509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia.
    Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T
    J Androl; 2009; 30(3):240-7. PubMed ID: 19136389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
    Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
    Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 years.
    Chen S; Zhu L; Cai J; Zheng Z; Ge R; Wu M; Deng Z; Zhou H; Yang S; Wu W; Liao L; Tan J
    Eur Urol; 2014 Aug; 66(2):284-91. PubMed ID: 24502959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mepartricin long-term administration regulates steroid hormone and adrenergic receptor concentrations in the prostate of aged rats.
    Barbero R; Badino P; Odore R; Galmozzi MR; Cuniberti B; Zanatta R; Re G
    J Vet Pharmacol Ther; 2006 Aug; 29(4):289-97. PubMed ID: 16846466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional variation of cytosol androgen receptors throughout the diseased human prostate gland.
    Bowman SP; Barnes DM; Blacklock NJ; Sullivan PJ
    Prostate; 1986; 8(2):167-80. PubMed ID: 2419881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.